|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -0.40% |
|
-24.10% | -79.41% |
| 06-30 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
9f8ca229737f7a89422f06d949b.mtDj4Lu3WDTkp3dGFVfnCHhs1Bsq_0E0A91sU_KRcAo.3aaslfDdCAOz7yUsTwOvTStfgnJErQQZT5cHNojXPlD1gbWLw8I0A6HdEA~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +691.87% | |||||
| +18.07% | |||||
| +11.05% | |||||
| +31.98% | |||||
| +82.65% | |||||
| +19.98% | |||||
| +25.63% | |||||
| +7.98% | |||||
| -6.67% | |||||
| -6.44% | |||||
| Average | +87.61% | |||||
| Weighted average by Cap. | +21.20% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.260USD
Average target price
9.978USD
Spread / Average Target
+691.87%
High Price Target
14.91USD
Spread / Highest target
+1,083.33%
Low Price Target
5.000USD
Spread / Lowest Target
+296.83%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| B. Riley |
SellBuy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.260USD
Average target price
9.978USD
Spread / Average Target
+691.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
